NEW YORK--(BUSINESS WIRE)--The New York Biotechnology Association, the voice of New York’s bioscience industry, has launched a new roundtable series focused on bringing together New York’s bioscience elite with the next generation of entrepreneurs. NYBA’s “CEO Breakfast Club” will meet six times throughout the year, with each breakfast headlined by one of New York’s bioscience leaders. Each breakfast is limited to only 20 bioscience executives; the exclusive sponsor of the CEO Breakfast Club is BioMed Realty Trust, one of New York’s leading bioscience real estate developers.
The CEO Breakfast Club kicked off in February in a sold-out event with one of New York’s most successful biotech executives, Dr. Sam Waksal, CEO of Kadmon Corp and former founder and CEO of ImClone Systems. On April 9, Dr. Barbara Dalton, head of Pfizer Venture Investments, will headline another sold-out breakfast. Upcoming CEO Breakfast Club speakers include
- June 14, Dr. Robert Nowinkski, CEO of ContraFect and founder of seven biotech companies;
- October 8, Dr. Colin Goddard, CEO of Coferon and former CEO of OSI Pharmaceuticals;
- and, December 17, Dr. Ron Cohen, CEO of Acorda Therapeutics.
“The CEO Breakfast Club gives the leadership of New York’s emerging companies the opportunity to sit down in an intimate setting with the men and women who have created and built New York’s bioscience community,” said Nathan Tinker, Executive Director of NYBA. “We call it 'brewing better biotech': passing along the experience and know-how of our entrepreneurial elite to the next generation of biotech leaders. The goal of the CEO Breakfast Club is to continue to develop and nurture New York’s biotech leaders, turning entrepreneurs into serial entrepreneurs.”
NYBA CEO Breakfast Club is one of many events specifically tailored to New York’s thriving bioscience community. For more information, go to www.nyba.org.
NYBA is the leading advocate for advancing the success of the life science industry in New York State and is its main representative to state policy makers, the media and communities. NYBA’s mission is to support the development and growth of New York’s life science industry, and serve our members and the life science community by providing a network for information exchange, shared services and collective action. NYBA’s membership comprises bioscience companies, world-class research institutions and related professional services. Under the banner of The Cures Start Here®, the Association’s goal is to amplify the success New York has had and continues to have in growing a vibrant life science industry. http://www.nyba.org